These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 20449793

  • 41. The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.
    Sörensen S, White K, Mak W, Zanibbi K, Tang W, O'Hearn A, Hegel MT.
    Contemp Clin Trials; 2015 May; 42():68-77. PubMed ID: 25812482
    [Abstract] [Full Text] [Related]

  • 42. The impact of vision loss from age-related macular degeneration: a review (Part 2).
    Orticio LP.
    Insight; 2012 May; 37(1):9-11. PubMed ID: 22439351
    [No Abstract] [Full Text] [Related]

  • 43. [Quality of life by limited vision in old age: the example of age-related macula degeneration].
    Wahl HW, Heyl V, Langer N.
    Ophthalmologe; 2008 Aug; 105(8):735-43. PubMed ID: 18629508
    [Abstract] [Full Text] [Related]

  • 44. Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.
    Rovner BW, Casten RJ, Hegel MT, Massof RW, Leiby BE, Tasman WS.
    Contemp Clin Trials; 2011 Mar; 32(2):196-203. PubMed ID: 20974293
    [Abstract] [Full Text] [Related]

  • 45. Impact of age related macular degeneration on quality of life.
    Hassell JB, Lamoureux EL, Keeffe JE.
    Br J Ophthalmol; 2006 May; 90(5):593-6. PubMed ID: 16622089
    [Abstract] [Full Text] [Related]

  • 46. Age-related macular degeneration and quality of life: how to interpret a research paper in health-related quality of life.
    Sharma S, Oliver-Fernandez A.
    Curr Opin Ophthalmol; 2004 Jun; 15(3):227-31. PubMed ID: 15118510
    [Abstract] [Full Text] [Related]

  • 47. Age-related macular degeneration and low-vision rehabilitation: a systematic review.
    Hooper P, Jutai JW, Strong G, Russell-Minda E.
    Can J Ophthalmol; 2008 Apr; 43(2):180-7. PubMed ID: 18347620
    [Abstract] [Full Text] [Related]

  • 48. [The influence of visual rehabilitation on secondary depressive disorders due to age-related macular degeneration. A randomized controlled pilot study].
    Mielke A, Wirkus K, Niebler R, Eschweiler G, Nguyen NX, Trauzettel-Klosinski S.
    Ophthalmologe; 2013 May; 110(5):433-40. PubMed ID: 23380979
    [Abstract] [Full Text] [Related]

  • 49. Clinical management of age-related macular degeneration: room for improvement.
    Howe LJ.
    Eye (Lond); 1995 May; 9 ( Pt 6 Su)():42-6. PubMed ID: 8729019
    [Abstract] [Full Text] [Related]

  • 50. Age-related macular degeneration: economic burden and value-based medicine analysis.
    Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR.
    Can J Ophthalmol; 2005 Jun; 40(3):277-87. PubMed ID: 15947797
    [Abstract] [Full Text] [Related]

  • 51. What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research.
    Bennion AE, Shaw RL, Gibson JM.
    Soc Sci Med; 2012 Sep; 75(6):976-85. PubMed ID: 22709445
    [Abstract] [Full Text] [Related]

  • 52. Implantable vision-enhancing devices and postoperative rehabilitation in advanced age-related macular degeneration.
    Borkenstein AF, Borkenstein EM, Augustin AJ.
    Eye (Lond); 2023 Mar; 37(4):597-606. PubMed ID: 35869389
    [Abstract] [Full Text] [Related]

  • 53. Optimizing the functionality of clients with age-related macular degeneration.
    McGrory A, Remington R.
    Rehabil Nurs; 2004 Mar; 29(3):90-4. PubMed ID: 15152418
    [Abstract] [Full Text] [Related]

  • 54. Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL).
    Borkenstein AF, Borkenstein EM, Persson S, Muus G, Nielsen NV.
    Clin Ophthalmol; 2021 Mar; 15():3333-3339. PubMed ID: 34408391
    [Abstract] [Full Text] [Related]

  • 55. Age-related macular degeneration and depression: a review of recent research.
    Casten RJ, Rovner BW, Tasman W.
    Curr Opin Ophthalmol; 2004 Jun; 15(3):181-3. PubMed ID: 15118503
    [Abstract] [Full Text] [Related]

  • 56. Additional psychometric information and vision-specific questionnaires are available for age-related macular degeneration.
    van Nispen RM, de Boer MR, van Rens GH.
    Qual Life Res; 2009 Feb; 18(1):65-9. PubMed ID: 19067235
    [Abstract] [Full Text] [Related]

  • 57. Age related macular degeneration.
    Chakravarthy U.
    BMJ; 2006 Oct 28; 333(7574):869-70. PubMed ID: 17068017
    [No Abstract] [Full Text] [Related]

  • 58. [Methods for estimating personal costs of disease using retinal diseases as an example].
    Porz G, Scholl HP, Holz FG, Finger RP.
    Ophthalmologe; 2010 Mar 28; 107(3):216-20, 222. PubMed ID: 20195614
    [Abstract] [Full Text] [Related]

  • 59. Dignified blindness and age-related macular degeneration. A necessary multidisciplinary approach.
    Fernández-Vigo JÁ, Fernández-Vigo JI, Serrano Garijo P, Donate-López J.
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov 28; 93(11):519-522. PubMed ID: 29929760
    [No Abstract] [Full Text] [Related]

  • 60. [A psychosocial training program for elderly patients with age-related macular degeneration: findings of a pilot evaluation study].
    Birk T, Hickl S, Wahl HW, Kämmerer A, Miller D, Holz F, Becker S.
    Z Gerontol Geriatr; 2004 Oct 28; 37(5):363-5. PubMed ID: 15503074
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.